These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 14764751

  • 1. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 3. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC, Rossi A, Martinelli CE, Machado HR, Moreira AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [Abstract] [Full Text] [Related]

  • 4. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O, Beauregard C, Hardy J.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [Abstract] [Full Text] [Related]

  • 5. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC.
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly.
    Freda PU, Bruce JN, Reyes-Vidal C, Singh S, DeLeon Y, Jin Z, Khandji AG, Cremers S, Post KD.
    Pituitary; 2021 Apr; 24(2):170-183. PubMed ID: 33124000
    [Abstract] [Full Text] [Related]

  • 7. Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria.
    Ronchi CL, Varca V, Giavoli C, Epaminonda P, Beck-Peccoz P, Spada A, Arosio M.
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1377-82. PubMed ID: 15585548
    [Abstract] [Full Text] [Related]

  • 8. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR, van Dulken H, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [Abstract] [Full Text] [Related]

  • 9. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
    Feelders RA, Bidlingmaier M, Strasburger CJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW, van der Lely AJ, de Herder WW.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6480-9. PubMed ID: 16159936
    [Abstract] [Full Text] [Related]

  • 10. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N, Morita K, Suzuki H, Takeshita A, Miyakawa M, Fukuhara N, Nishioka H, Yamada S, Takeuchi Y.
    Endocr J; 2016 May 31; 63(5):469-77. PubMed ID: 26949262
    [Abstract] [Full Text] [Related]

  • 11. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A, Mendoza V.
    J Neurosurg; 2002 Aug 31; 97(2):287-92. PubMed ID: 12186455
    [Abstract] [Full Text] [Related]

  • 12. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, Cappabianca P, Lombardi G.
    Clin Endocrinol (Oxf); 2006 Aug 31; 65(2):250-6. PubMed ID: 16886969
    [Abstract] [Full Text] [Related]

  • 13. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
    Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL.
    J Clin Endocrinol Metab; 2002 Aug 31; 87(8):3537-42. PubMed ID: 12161471
    [Abstract] [Full Text] [Related]

  • 14. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
    Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V.
    Eur J Endocrinol; 2006 May 31; 154(5):659-66. PubMed ID: 16645012
    [Abstract] [Full Text] [Related]

  • 15. Remission criteria for the follow-up of patients with acromegaly.
    Gullu S, Keles H, Delibasi T, Tonyukuk V, Kamel N, Erdogan G.
    Eur J Endocrinol; 2004 Apr 31; 150(4):465-71. PubMed ID: 15080775
    [Abstract] [Full Text] [Related]

  • 16. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
    Biermasz NR, Smit JW, van Dulken H, Roelfsema F.
    Clin Endocrinol (Oxf); 2002 Mar 31; 56(3):313-9. PubMed ID: 11940042
    [Abstract] [Full Text] [Related]

  • 17. Gender and age in the biochemical assessment of cure of acromegaly.
    Freda PU, Landman RE, Sundeen RE, Post KD.
    Pituitary; 2001 Aug 31; 4(3):163-71. PubMed ID: 12138989
    [Abstract] [Full Text] [Related]

  • 18. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
    Rotermund R, Burkhardt T, Rohani Z, Jung R, Aberle J, Flitsch J.
    Growth Horm IGF Res; 2018 Aug 31; 41():64-70. PubMed ID: 29555234
    [Abstract] [Full Text] [Related]

  • 19. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
    Kinoshita Y, Tominaga A, Usui S, Arita K, Sakoguchi T, Sugiyama K, Kurisu K.
    Neurosurg Rev; 2016 Apr 31; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
    Biermasz NR, van Dulken H, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Jul 31; 85(7):2476-82. PubMed ID: 10902796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.